For the year ending 2025-12-31, CPRX has $1,103,979K in assets. $149,711K in debts. $709,171K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 709,171 | |||
| Accounts receivable, net | 126,477 | |||
| Inventory, net | 37,166 | |||
| Prepaid expenses and other current assets | 21,216 | |||
| Total current assets | 894,030 | |||
| Operating lease right-of-use asset, net | 1,935 | |||
| Property and equipment, net | 1,037 | |||
| Gross carrying value | 240,212 | |||
| Accumulated amortization | 108,538 | |||
| License and acquired intangibles, net | 131,674 | |||
| Deferred tax assets, net | 52,767 | |||
| Investment in equity securities | 22,536 | |||
| Total assets | 1,103,979 | |||
| Accounts payable | 11,202 | |||
| Accrued expenses and other liabilities | 135,950 | |||
| Total current liabilities | 147,152 | |||
| Operating lease liability, net of current portion | 2,350 | |||
| Other non-current liabilities | 209 | |||
| Total liabilities | 149,711 | |||
| Common stock, 0.001 par value, 200,000,000 shares authorized 122,513,621 shares and 120,879,099 shares issued and outstanding at december 31 2025 and 2024, respectively | 123 | |||
| Additional paid-in capital | 479,957 | |||
| Retained earnings | 474,188 | |||
| Accumulated other comprehensive income (note 4) | 0 | |||
| Total stockholders' equity | 954,268 | |||
| Total liabilities and stockholders' equity | 1,103,979 | |||
CATALYST PHARMACEUTICALS, INC. (CPRX)
CATALYST PHARMACEUTICALS, INC. (CPRX)